SLC5A2 and Hypoglycemia: (1987) at Yale University unprecedently demonstrated that phlorizin completely normalized insulin sensitivity in diabetic rats without hypoglycemia—was a connection made between SGLT2 inhibitors and the treatment of diabetes.